Apple and Synchron Develop Brain-Controlled Device Technology for Enhanced Accessibility

Apple Inc. is partnering with neurotechnology company Synchron to develop cutting-edge devices that could revolutionize accessibility for people with disabilities. The collaboration focuses on integrating brain implants, specifically Synchron’s Stentrode, into everyday electronics like iPhones and iPads. The technology utilizes the Stentrode, a stent-like implant positioned within the motor cortex of the brain, to allow users with limited mobility to control these devices through their thoughts. This innovative approach leverages neural signals to translate complex commands into actions for smart devices.